Identification of sanguinarine as a novel HIV protease inhibitor from high-throughput screening of 2,000 drugs and natural products with a cell-based assay

Ting Jen Cheng, David S. Goodsell, Chen Chen Kan

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We identified a non-peptidomimetic HIV protease inhibitor sanguinarine through screening a small compound library with a high-throughput E. coli-based assay. In vitro, sanguinarine inhibits the HIV protease with an IC50 of around 13 μM. Based on docking results, binding modes of sanguinarine to the HIV protease are proposed.

Original languageEnglish (US)
Pages (from-to)364-371
Number of pages8
JournalLetters in Drug Design and Discovery
Volume2
Issue number5
DOIs
StatePublished - Aug 2005
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Keywords

  • E. coli-based system
  • HIV protease
  • HIV protease inhibitors
  • HIV protease precursor
  • High-throughput screening
  • Sanguinarine

Fingerprint

Dive into the research topics of 'Identification of sanguinarine as a novel HIV protease inhibitor from high-throughput screening of 2,000 drugs and natural products with a cell-based assay'. Together they form a unique fingerprint.

Cite this